Welcome to LookChem.com Sign In|Join Free

CAS

  • or

20782-91-6

Post Buying Request

20782-91-6 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

20782-91-6 Usage

General Description

4-(Bromomethyl)-3-nitrobenzoic acid is a chemical compound with the molecular formula C8H6BrNO4. It is a derivative of benzoic acid, with a bromomethyl and nitro group attached to the benzene ring. 4-(BROMOMETHYL)-3-NITROBENZOIC ACID is often used in organic synthesis and medicinal chemistry as a building block for creating more complex molecules. It is also known for its antimicrobial activity and is used in the development of pharmaceuticals and agrochemicals. Additionally, it has potential applications in the fields of dye production and material science due to its aromatic properties and functional groups.

Check Digit Verification of cas no

The CAS Registry Mumber 20782-91-6 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 2,0,7,8 and 2 respectively; the second part has 2 digits, 9 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 20782-91:
(7*2)+(6*0)+(5*7)+(4*8)+(3*2)+(2*9)+(1*1)=106
106 % 10 = 6
So 20782-91-6 is a valid CAS Registry Number.
InChI:InChI=1/C5H4BrNO3/c6-3-4-1-2-5(10-4)7(8)9/h1-2H,3H2

20782-91-6 Well-known Company Product Price

  • Brand
  • (Code)Product description
  • CAS number
  • Packaging
  • Price
  • Detail
  • Aldrich

  • (677329)  2-(Bromomethyl)-5-nitrofuran  97%

  • 20782-91-6

  • 677329-1G

  • 730.08CNY

  • Detail
  • Aldrich

  • (677329)  2-(Bromomethyl)-5-nitrofuran  97%

  • 20782-91-6

  • 677329-5G

  • 2,658.24CNY

  • Detail

20782-91-6SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 13, 2017

Revision Date: Aug 13, 2017

1.Identification

1.1 GHS Product identifier

Product name 4-(BROMOMETHYL)-3-NITROBENZOIC ACID

1.2 Other means of identification

Product number -
Other names 5-Nitro-2-Furfuryl Bromide (2-(Bromomethyl)-5-Nitrofuran)

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:20782-91-6 SDS

20782-91-6Relevant articles and documents

Synthesis, characterization and antiinflammatory activity of chalcone derivatives linked with apocynin and 5-nitrofuran moiety

Kumar Reddy,Kathale, Niren E.

, p. 312 - 316 (2018)

The present paper describes the synthesis of some new chalcone derivatives i.e. 1-[3-methoxy-4-(5-nitro-furan-2-ylmethoxy)-phenyl]-3-(substituted phenyl)-propenone derivatives (9A-9K) from furfural and apocynin as starting materials. Claisen-Schmidt reaction of 1-(4-((5-nitrofuran-2-yl)methoxy)-3-methoxyphenyl)ethanone (7) with aromatic aldehydes (8A-K) under solvent free conditions using solid NaOH as catalyst at room temperature resulted in the formation of chalcone derivatives (9A-9K) in 86-96 % yield. These compounds were characterized by 1H NMR, Mass and IR spectroscopy and were evaluated for their anti-inflammatory activity.

Design, synthesis, biological screening and molecular docking studies of novel multifunctional 1,4-di (aryl/heteroaryl) substituted piperazine derivatives as potential antitubercular and antimicrobial agents

Mekonnen Sanka, Bruktawit,Mamo Tadesse, Dereje,Teju Bedada, Endale,Mengesha, Ephriem T.,Babu G., Neelaiah

, (2022/01/20)

In this paper, two series of novel multifunctional 1, 4-di (aryl/heteroaryl) substituted piperazine derivatives (6a-d & 7a-d) were synthesized, characterized, and evaluated for their antitubercular, antibacterial, and antifungal activities. A step-wise reduction, bromination and substitution reactions on various aldehydes resulted in alcohols (2a–d), bromides (3a–d), and titled novel compounds (6a–d & 7a–d) in moderate to good yields (48–85%). The novel compounds were evaluated for their antitubercular and antimicrobial activities. Compound 7a exhibited promising antitubercular activity (MIC: 0.65 μg/mL) almost equal to the Rifampicin, while the rest of the compounds were moderately active against MTB H37Rv except 6b. Compounds 7a and 6b showed good activity against tested fungal pathogens. Compounds 7a and 7b were proven as the best bacterial agents. Molecular docking studies were in agreement with the in-vitro results. Docking analyses show that all the synthesized molecules bind to the target protein Mtb RNAP (PDB ID: 5UHC) fairly strongly. All the compounds were evaluated for their in vitro cytotoxicity effect using the MTT assay method against human cancer cell line MCF-7. The compounds demonstrated growth inhibitory effect on the cell line with significant IC50 values ranging between 8.20 and 34.45 μM. Most importantly, compound 7a displayed good binding affinity towards the tested protein with binding energy ?7.30 kcal/mol and a stronger hydrogen bond distance of 2.2 ? with ASN-493 residue. Thus, the present research highlighted the potential role of novel piperazine derivatives as potential antitubercular, and antimicrobial candidates and further good research into optimization might result in the development of new antitubercular drug candidates.

ANTIBACTERIAL THERAPEUTICS AND PROPHYLACTICS

-

Paragraph 00310, (2017/02/24)

The present disclosure relates generally to novel molecules, compositions, and formulations for treatment of bacterial infections in general and more specifically to bacterial infections with antibiotic resistant pathogens.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 20782-91-6